Provided by Tiger Trade Technology Pte. Ltd.

Vir Biotechnology, Inc.

9.78
+0.57006.19%
Post-market: 9.780.00000.00%19:30 EDT
Volume:1.76M
Turnover:17.03M
Market Cap:1.65B
PE:-5.76
High:9.86
Open:9.31
Low:9.31
Close:9.21
52wk High:11.66
52wk Low:4.35
Shares:168.65M
Float Shares:130.00M
Volume Ratio:1.24
T/O Rate:1.35%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6972
EPS(LYR):-3.1619
ROE:-26.08%
ROA:-14.51%
PB:1.68
PE(LYR):-3.09

Loading ...

Trump Will Impose 100% Tariff on Some Patented Drugs

Tiger Newspress
·
Apr 03

Vir director Vicki L. Sato disposes Vir Biotechnology shares worth $0.2 million

Reuters
·
Apr 02

Vir Biotechnology SVP and Chief Accounting Officer Brent Sabatini disposes of USD 70,332 in common shares

Reuters
·
Mar 25

Vir Biotechnology Inc - Appoints Marianne De Backer as President in Addition to CEO on March 4, 2026 - SEC Filing

THOMSON REUTERS
·
Mar 05

Vir Biotech Names CEO Marianne De Backer President

Reuters
·
Mar 05

Vir Biotechnology Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Mar 04

Vir Biotechnology price target raised to $20 from $15 at H.C. Wainwright

TIPRANKS
·
Mar 04

Vir Biotechnology Director Vicki L Sato Disposes of Common Shares

Reuters
·
Mar 04

Vir Biotechnology EVP and General Counsel Vanina de Verneuil Disposes of Common Shares

Reuters
·
Feb 27

Top Premarket Decliners

MT Newswires Live
·
Feb 26

BUZZ-Vir Biotech drops after $150 mln stock sale

Reuters
·
Feb 26

Stock Track | Vir Biotechnology Plunges 7.80% in Pre-market After Pricing Public Offering at $8.50 Per Share

Stock Track
·
Feb 26

Stock Track | Vir Biotechnology Plunges 5% After Pricing Public Offering at $8.50 Per Share

Stock Track
·
Feb 26

BRIEF-Vir Biotechnology Announces Pricing Of Public Offering Of Common Stock At $8.50 Per Share

Reuters
·
Feb 26

Vir Biotechnology Inc - Prices Public Offering at $8.50 per Share

THOMSON REUTERS
·
Feb 26

Vir Biotechnology Is Maintained at Overweight by Barclays

Dow Jones
·
Feb 26

Stock Track | Vir Biotechnology Soars 5.82% Intraday After Barclays Raises Price Target to $30

Stock Track
·
Feb 25

Stock Track | Vir Biotechnology Plunges 5.06% Post-Market Following $200 Million Stock Offering Announcement

Stock Track
·
Feb 25

Vir Biotechnology’s Call Highlights Astellas Deal, VIR-5500 Momentum

TIPRANKS
·
Feb 25

BUZZ-Vir Biotech slips after unveiling $200 mln stock offering plans

Reuters
·
Feb 25